External Professional Relationships and Financial Interests

Share

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

and/or
1 Employee found
Back to Main Page
Pediatric Hematologist-Oncologist
Nai-Kong V Cheung

View Nai-Kong V Cheung’s profile

  • Abpro Inc
    Equity; Intellectual Property Rights
  • Biotec Pharmacon
    Intellectual Property Rights
  • Eureka Therapeutics Inc
    Equity
  • Y-mAbs Therapeutics, Inc.
    Equity; Intellectual Property Rights

If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].